vs
Side-by-side financial comparison of Cardiff Oncology, Inc. (CRDF) and TREASURE GLOBAL INC (TGL). Click either name above to swap in a different company.
Cardiff Oncology, Inc. is the larger business by last-quarter revenue ($243.0K vs $182.5K, roughly 1.3× TREASURE GLOBAL INC). TREASURE GLOBAL INC runs the higher net margin — -1169.1% vs -2969.5%, a 1800.5% gap on every dollar of revenue. On growth, Cardiff Oncology, Inc. posted the faster year-over-year revenue change (62.0% vs -12.0%). Over the past eight quarters, Cardiff Oncology, Inc.'s revenue compounded faster (8.9% CAGR vs -83.5%).
Treasure Global Inc is a consumer technology company offering integrated digital commerce solutions, customer loyalty rewards programs, and cashless payment services. It primarily operates across Southeast Asian markets, serving individual users and small-to-medium enterprise clients.
CRDF vs TGL — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $243.0K | $182.5K |
| Net Profit | $-7.2M | $-2.1M |
| Gross Margin | — | 0.7% |
| Operating Margin | -3221.0% | -953.5% |
| Net Margin | -2969.5% | -1169.1% |
| Revenue YoY | 62.0% | -12.0% |
| Net Profit YoY | 38.8% | -124.5% |
| EPS (diluted) | $-0.11 | $-0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $243.0K | — | ||
| Q3 25 | $120.0K | $182.5K | ||
| Q2 25 | $121.0K | $1.2M | ||
| Q1 25 | $109.0K | $666.5K | ||
| Q4 24 | $150.0K | $301.9K | ||
| Q3 24 | $165.0K | $207.4K | ||
| Q2 24 | $163.0K | $293.0K | ||
| Q1 24 | $205.0K | $1.6M |
| Q4 25 | $-7.2M | — | ||
| Q3 25 | $-11.3M | $-2.1M | ||
| Q2 25 | $-13.9M | — | ||
| Q1 25 | $-13.4M | $1.3M | ||
| Q4 24 | $-11.8M | $-232.3K | ||
| Q3 24 | $-11.9M | $-950.7K | ||
| Q2 24 | $-11.8M | — | ||
| Q1 24 | $-10.0M | $-1.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 68.2% | ||
| Q1 25 | — | 73.0% | ||
| Q4 24 | — | 74.2% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 31.0% | ||
| Q1 24 | — | 13.6% |
| Q4 25 | -3221.0% | — | ||
| Q3 25 | -9978.3% | -953.5% | ||
| Q2 25 | -12212.4% | — | ||
| Q1 25 | -13194.5% | -6.5% | ||
| Q4 24 | -8381.3% | -229.5% | ||
| Q3 24 | -7637.0% | -391.4% | ||
| Q2 24 | -7696.3% | — | ||
| Q1 24 | -5333.2% | -85.9% |
| Q4 25 | -2969.5% | — | ||
| Q3 25 | -9381.7% | -1169.1% | ||
| Q2 25 | -11523.1% | — | ||
| Q1 25 | -12324.8% | 189.0% | ||
| Q4 24 | -7858.0% | -77.0% | ||
| Q3 24 | -7184.8% | -458.5% | ||
| Q2 24 | -7225.8% | — | ||
| Q1 24 | -4883.4% | -107.3% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.17 | $-0.38 | ||
| Q2 25 | $-0.21 | — | ||
| Q1 25 | $-0.20 | $1.09 | ||
| Q4 24 | $-0.22 | $-11.32 | ||
| Q3 24 | $-0.25 | $-17.62 | ||
| Q2 24 | $-0.26 | — | ||
| Q1 24 | $-0.22 | $-116.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $58.3M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $45.4M | $12.0M |
| Total Assets | $61.9M | $16.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $58.3M | — | ||
| Q3 25 | $60.6M | — | ||
| Q2 25 | $71.0M | — | ||
| Q1 25 | $79.9M | $2.5K | ||
| Q4 24 | $91.7M | $504.3K | ||
| Q3 24 | $57.7M | $44.1K | ||
| Q2 24 | $60.3M | $171.6K | ||
| Q1 24 | $67.2M | — |
| Q4 25 | $45.4M | — | ||
| Q3 25 | $48.8M | $12.0M | ||
| Q2 25 | $58.6M | $10.7M | ||
| Q1 25 | $70.9M | $29.1M | ||
| Q4 24 | $82.9M | $18.4M | ||
| Q3 24 | $49.4M | $6.3M | ||
| Q2 24 | $52.4M | $3.4M | ||
| Q1 24 | $60.9M | $3.1M |
| Q4 25 | $61.9M | — | ||
| Q3 25 | $63.8M | $16.6M | ||
| Q2 25 | $75.7M | $14.9M | ||
| Q1 25 | $84.8M | $30.4M | ||
| Q4 24 | $97.2M | $19.1M | ||
| Q3 24 | $62.9M | $7.1M | ||
| Q2 24 | $66.1M | $4.3M | ||
| Q1 24 | $74.0M | $4.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $-1.8M |
| Free Cash FlowOCF − Capex | — | $-2.4M |
| FCF MarginFCF / Revenue | — | -1318.2% |
| Capex IntensityCapex / Revenue | — | 353.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $-10.8M | $-1.8M | ||
| Q2 25 | $-8.3M | $-9.5M | ||
| Q1 25 | $-12.8M | $-4.2M | ||
| Q4 24 | $-10.3M | $-606.2K | ||
| Q3 24 | $-10.5M | $-976.3K | ||
| Q2 24 | $-9.2M | $-4.7M | ||
| Q1 24 | $-7.7M | $-1.1M |
| Q4 25 | — | — | ||
| Q3 25 | $-10.9M | $-2.4M | ||
| Q2 25 | — | $-9.5M | ||
| Q1 25 | — | $-4.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-4.7M | ||
| Q1 24 | $-7.8M | $-1.1M |
| Q4 25 | — | — | ||
| Q3 25 | -9043.3% | -1318.2% | ||
| Q2 25 | — | -822.4% | ||
| Q1 25 | — | -635.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1614.2% | ||
| Q1 24 | -3814.6% | -67.1% |
| Q4 25 | — | — | ||
| Q3 25 | 15.0% | 353.3% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | 5.7% | ||
| Q1 24 | 39.0% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -3.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
